2m 2m 2m 2m 2m 2m 2m
Akebia Therapeut (AKBA)
NASDAQ
$0.92+$0.02 (+1.92%)
Price as of Aug 21, 2026 7:55 PM EDT- $251.2MMarket Cap
- -71.58%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Akebia Therapeut (AKBA)
$0.92+$0.02 (+1.92%)
AKBA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.91 | ||
Change | -$0.01 (-1.39%) | ||
Open | $0.92 | ||
High | $0.95 | ||
Low | $0.91 | ||
Previous Close | $0.92 | ||
Volume | 6,450,124 | ||
30-Day Average Volume | 4,920,151 | ||
1-Week Change | 3.87% | ||
1-Month Change | -30.26% | ||
1-Year Change | -71.58% | ||
3-Year Change | -26.29% | ||
5-Year Change | -63.88% | ||
Fundamentals | |||
Shares Outstanding | 277.1M | ||
Total Assets | $349.7M | ||
Market Cap | $251.2M | ||
Enterprise Value | $145.2M | ||
Period: QTR TTM FY | |||
Revenue | $46.8M | ||
Net Income | -$8.9M | ||
Free Cash Flow | $2.4M | ||
EBIT | -$5.8M | ||
EBITDA | -$5.2M | ||
Net Working Capital | $68.7M | ||
EPS | -$0.03 | ||
Enterprise Value/EBITDA | -28 | ||
Enterprise Value/Revenue | 3 | ||
P/B | 10 | ||
P/E | -30 | ||
PEG | N/A | ||
Price/Free Cash Flow | 103 | ||
Price/Operating Cash Flow | 71 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue